Aurinia Pharmaceuticals
AUPH
AUPH
114 hedge funds and large institutions have $991M invested in Aurinia Pharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 28 increasing their positions, 19 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
47% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 19
17.91% more ownership
Funds ownership: 27.74% → 45.65% (+18%)
Holders
114
Holding in Top 10
6
Calls
$89.1M
Puts
$39.3M
Top Buyers
| 1 | +$140M | |
| 2 | +$82.3M | |
| 3 | +$80.8M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$72.4M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$34.5M |
Top Sellers
| 1 | -$24M | |
| 2 | -$20.9M | |
| 3 | -$17.7M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$4.3M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.79M |